news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

source: china economic net

china economic net, beijing, september 18th. beike biopharmaceuticals (688276.sh) disclosed an announcement that the company received a "notice on share reduction plan" issued by shareholder wei xue ning on september 13, 2024. wei xue ning plans to reduce his holdings of the company's shares by no more than 500,000 shares through centralized bidding according to market conditions. the number of shares to be reduced will account for no more than 0.1209% of the company's total share capital. the reduction period is within 3 months after 15 trading days after the announcement is disclosed.

as of the date of disclosure of the announcement, wei xue ning holds 20,954,688 shares of the company, accounting for 5.07% of the company's total share capital. the above shares are all from the shares held by the company before its initial public offering and will be listed and circulated on june 27, 2022.

beike biopharmaceuticals was listed on the shanghai stock exchange science and technology innovation board on june 25, 2021. the company's public offering of 41.2841 million shares accounted for 10.00% of the total share capital after this issuance. the issue price was 36.35 yuan per share. the sponsor was citic securities co., ltd., and the sponsor representatives were dong zhiru and zhu shaohui. the stock price is currently below the issue price.